Beam Therapeutics BEAM
NASDAQ BEAM
$24.27 -0.57 (-2.29%)
As of: Oct 22, 2026 · 1:12 PM EDT

Beam Therapeutics (BEAM) Acquisitions (2021)

Updated

Beam Therapeutics (BEAM) reported Acquisitions of $78,000 for FY2025.

Analysis

Beam Therapeutics (BEAM) Acquisitions (2021) Analysis & Trends

  • Acquisitions has a four-year compound annual growth rate of -40.4% (FY2021 to FY2025).
  • The FY2025 figure ranks as the highest annual Acquisitions since FY2021.
  • According to Business Quant data, Acquisitions came in at $620,000 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Eli Lilly 1,166.97 Bn 1,135.56 Bn 19.71 Bn 8.75 Bn
2 Johnson & Johnson 644.38 Bn 564.24 Bn 17.30 Bn -17.15 Bn
3 AbbVie 501.54 Bn 474.65 Bn 12.70 Bn -
4 Merck 359.36 Bn 313.74 Bn 12.21 Bn -
5 Novartis Ag 302.13 Bn 266.12 Bn 11.24 Bn 23.00 Mn
6 Astrazeneca 267.59 Bn 241.28 Bn 12.86 Bn -
7 Amgen 241.49 Bn 196.89 Bn 7.24 Bn -
8 Gilead Sciences 192.85 Bn 167.05 Bn 6.22 Bn 11.21 Bn
9 Pfizer 171.77 Bn 118.41 Bn 10.94 Bn -
10 Beam Therapeutics 2.53 Bn -2.15 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -620,000.00
API Access

Beam Therapeutics Acquisitions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=acquisitions&ticker=BEAM&period=max&api_key=YOUR_API_KEY